| 2024-04-08 | Sale | Phathom Pharmaceuticals, Inc. PHAT | CFO and CBO | 3,435 0.0059% | $11.10 | $38,129 | -7.2% | |
| 2024-01-19 | Sale | Phathom Pharmaceuticals, Inc. PHAT | CFO and CBO | 6,307 0.0114% | $7.75 | $48,900 | +34.09% | |
| 2023-11-20 | Sale | Phathom Pharmaceuticals, Inc. PHAT | CFO and CBO | 2,127 0.0037% | $7.24 | $15,403 | +23.09% | |
| 2023-11-01 | Sale | Phathom Pharmaceuticals, Inc. PHAT | CFO and CBO | 12,492 0.0202% | $8.88 | $110,871 | -5.31% | |
| 2023-06-02 | Sale | Phathom Pharmaceuticals, Inc. PHAT | CFO and CBO | 1,960 0.0045% | $11.41 | $22,368 | -13.46% | |
| 2023-05-22 | Sale | Phathom Pharmaceuticals, Inc. PHAT | CFO and CBO | 2,110 0.0048% | $12.87 | $27,165 | -24.78% | |
| 2023-04-06 | Sale | Phathom Pharmaceuticals, Inc. PHAT | CFO and CBO | 3,439 0.0079% | $7.27 | $25,002 | +34.68% | |
| 2023-03-01 | Sale | Phathom Pharmaceuticals, Inc. PHAT | CFO and CBO | 2,032 0.0047% | $8.53 | $17,335 | +13.21% | |
| 2022-11-21 | Sale | Phathom Pharmaceuticals, Inc. PHAT | CFO and CBO | 2,159 0.0054% | $9.60 | $20,726 | +9.39% | |
| 2022-05-13 | Phathom Pharmaceuticals, Inc. PHAT | CFO and CBO | 6,000 – | $0 | $0 | +21.9% | ||
| 2022-01-31 | Sale | UroGen Pharma Ltd. URGN | Chief Financial Officer | 331 0.0014% | $7.58 | $2,509 | +5.96% | |
| 2021-11-30 | Sale | UroGen Pharma Ltd. URGN | Chief Financial Officer | 2,587 0.0115% | $12.03 | $31,122 | -31.97% | |
| 2021-05-17 | UroGen Pharma Ltd. URGN | Chief Financial Officer | 5,000 0.0222% | $15.85 | $79,250 | -10.34% |